Skip to content
Latest News
Nuformix Shares Surged 19.3% on Exclusive Cancer Drug Licensing Deal With Oxilio

Shares of Nuformix PLC (LON: NFX) surged 19.3% after signing an exclusive licensing deal with Oxilio Ltd to develop and commercialise its NXP001 cancer drug candidate. According to the agreement, Oxilio will develop, research and market NXP001 wor

Simon Mugo
Genedrive (GDR) Shares Plunge After Announcing Placing and Open Offer To Raise Over £10m

Shares of Genedrive (LON: GDR) have plunged on Friday after the company announced a placing to raise up to £6 million and an open offer to qualifying shareholders to raise up to £4.5 million. The company will be placing up to 24 million new shares

Sam Boughedda
Audioboom Shares Fell 6.82% After AAA Fails To Submit Revised Offer, Looming Deadline

Shares of Audioboom Group PLC (LON: BOOM) plunged 6.82% after an update indicating that All Active Asset Management (AAA) had not submitted a revised offer to acquire the company after its £188.3 million offer was rejected for having a low valuation.

Simon Mugo
Clinigen Shares Surged 9.94% on Rumours That It Could Be an Acquisition Target

Shares of Clinigen Group PLC (LON: CLIN) surged 9.94% on rumours that it could be the next acquisition target for Elliott Investment Management LP, which recently acquired a 5% stake in the company. The specialist pharmaceutical services company r

Simon Mugo
Gresham House Shares Edge Higher After Acquiring Mobeus Equity’s VC Division

Shares of Gresham House plc (LON: GHE) edged 1.34% higher after acquiring Mobeus Equity Partners’ Venture Capital Trust (VCT) business. The transaction will cost £36.1 million, with Gresham intending to fund the purchase via a £40 million share pl

Simon Mugo
IQ-AI Shares Fell 2.6% After Postponing Phase I Clinical Trial for Brain Tumour Drug

Shares of IQ-AI Ltd (LON: IQAI) fell 2.6% after postponing the start of its Gallium Maltolate phase I clinical trial to the fourth quarter due to a delay in the production and delivery of the drug’s encapsulation by the supplier. The trial was sch

Simon Mugo
Panthera Resources (PAT) Shares Surge On Additional High-Grade Gold Mineralisation at Bassala

Shares of Panthera Resources (LON: PAT) have surged on Friday after the company said assay results from the recent air-core (AC) drilling programme at Bassala have confirmed the presence of additional significant gold mineralisation. The results a

Sam Boughedda
Impel NeuroPharma Stock Falls After Pricing Public Offering

Impel NeuroPharma (NASDAQ: IMPL) shares are down premarket on Friday after it announced its $45 million public offering pricing. The company is offering 3 million shares of its stock at a price of $15 per share. Before deducting expenses, the gros

Sam Boughedda
T2 Biosystems (TTOO) Stock Gains On Confirmation COVID Test Can Detect Mu Variant

Shares of T2 Biosystems (NASDAQ: TTOO) gained in after-hours and premarket trading on news that its T2SARS-CoV-2 Panel is capable of detecting the Mu and Iota variants of the coronavirus.

Sam Boughedda
Yourgene Health (YGEN) Shares Rally On DHSC Contract

AIM-listed Yourgene Health's share price is rallying on Friday after the company said a Contract Award Notice has been published regarding its contract with the Department of Health & Social Care. The contract is the first to come from the Nat

Sam Boughedda
Argo Blockchain (ARB) Shares Rally On Bitcoin Backed Loan

Shares of cryptocurrency mining firm Argo Blockchain (LON: ARB) have jumped on Friday after the company announced it has entered into an £18.05 million ($25 million) loan agreement. The agreement, which has a maturity date of October 29, 2021, is

Sam Boughedda
Analysts Raise Lululemon (LULU) Stock Price Targets Following Earnings

Lululemon (NASDAQ: LULU) shares are up over 12% on Thursday after it published its second-quarter earnings report. The athletic apparel retailer reported earnings of $1.6

Sam Boughedda
Carnival PLC (CCL) Shares Fell 2.94% on Further Cruise Cancellations Into Next Year

Carnival plc (LON: CCL) shares fell 2.94% after announcing a further round of cruise cancellations affecting its Holland America Line and its Seabourn branded cruise ships. The cruise ship operator unveiled plans to return its entire fleet of vess

Simon Mugo
Associated British Foods (ABF) Shares Are Down 15% This Year. Can They Rebound?

Shares of Associated British Foods plc (LON: ABF) are down almost 15% this year after the company reported lower grocery sales figures compared to last year when the UK was under the first wave of lockdowns. The British multinational food processi

Simon Mugo
Saga Shares Are Up 33.4% in 2021. Will They Keep Rising Despite Imminent Threats?

Shares of Saga PLC (LON: SAGA) are up 33.4% in 2021 despite the spread of new variants of the coronavirus pandemic that threaten the global travel industry. The company, which specialises in organising trips and tours for people over 50, had seen

Simon Mugo
Centamin (CEY) Shares Are Trading at Lows, Last Seen in March 2020. Can They Recover?

Shares of Centamin PLC (LON: CEY) are down 24.4% this year and are trading at the lows last seen in March 2020. Can they reverse course and rally higher? The gold mining company’s shares recently broker below a significant support level that was i

Simon Mugo
Soligenix (SGNX) Stock Rises Premarket After FDA Orphan Drug Designation

Soligenix (NASDAQ: SNGX) shares are rallying premarket on Thursday after the U.S. Food and Drug Administration (FDA) granted orphan drug designation to the active ingredient hypericin to treat T-cell lymphoma. The decision from the FDA extends the

Sam Boughedda
DraftKings Launches Online Sportsbook In Arizona, Shares Edge Lower Premarket

DraftKings (NASDAQ: DKNG) shares are slightly lower premarket after the company announced the launch of its online Sportsbook in Arizona. Arizona becomes the 14th state where the sportsbook is available. Using the app, Arizona sports fans age 2

Sam Boughedda
Humanigen (HGEN) Shares Plunge After FDA Declines EUA Request

Humanigen (NASDAQ: HGEN) shares have plunged over 50% premarket after the FDA declined its request for emergency use authorization of lenzilumab to treat newly hospitalized COVID-19 patients. According to Humanigen, the FDA stated in its letter th

Sam Boughedda
Cizzle Biotechnology Shares Rally on Encouraging St George Street Capital Collaboration Progress

Diagnostics Developer Cizzle Biotechnology (LON: CIZ) said it had seen encouraging progress in its collaboration with St George Street Capital (SGSC). In June, Cizzle announced it had signed a Memorandum of Understanding (MoU) with SGSC covering a

Sam Boughedda